Skip to content

Immediate Dental Implant Placed in the Presence of Chronic Inflammatory Periapical Lesions

Evaluating the Osseointegration of Immediate Dental Implant Placed in the Presence of Chronic Inflammatory Periapical Lesions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05101941
Enrollment
12
Registered
2021-11-01
Start date
2020-12-08
Completion date
2021-10-07
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immediate Dental Implant, Periapical; Infection, Tooth Exratction

Brief summary

Compromised teeth with periapical pathologies are removed before dental implant placement and sockets are left to heal. Some clinicians began to immediately place dental implants in fresh extraction sockets associated with chronic inflammatory periapical lesions and these studies revealed high success rates

Detailed description

12 implants will be immediately placed in sockets associated with chronic periapical granuloma. Clinical (Wound healing, Pain, swelling, implant stability) and radiographic parameters (Peri-implant radiolucency) will be evaluated

Interventions

Implants will be immediately placed in sockets associated with chronic periapical granuloma Extraction of non-restorable Teeth with periapical granuloma and socket debridement will be done then implants will be placed

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients ranging from 18 to 45 years with no gender predilection agreed to come for minimum follow-up visits for 6 months. * Adequate bone beyond teeth apices without jeopardizing any anatomical structure. * Single rooted mandibular teeth with chronic inflammatory periapical lesions represented as periapical radiolucency, pulp necrosis, sinus tract, failed RCT.

Exclusion criteria

* Smokers and alcoholics. * Medically compromised patients having uncontrolled diabetes or coagulation disorders. * Restorable teeth. * Periodontitis.

Design outcomes

Primary

MeasureTime frameDescription
Change in Implant stabilityimmediately, at 3 months and 6 monthsIt will be measured by implant stability meter (Osstell™)
Change in peri implant radiolucencyimmediately, and 6 monthsImmediate post-operative and after 6 months CBCT will be requested in order to compare the dimension of the periapical lesion in millimeters using OnDemand system.

Secondary

MeasureTime frameDescription
Change in pain scorewithin a weekIt will be recorded daily for the first week through a 10-point Visual Analogue Scale (VAS) from 0 to 10 (0-1= None, 2-4= Mild, 5-7= Moderate, 8-10= Severe).
Change in swelling statuswithin a weekIt will be recorded daily for the first week through a 10-point scale with 4 parameters will be used. none (no swelling), light (intraoral, localized to the treated area), moderate (extraoral swelling localized to the treated area), and severe (extraoral swelling extending beyond the treated area)
Change in Early Wound Healing Indexat 2 weeks, 4 weeks, and 8 weeksUsing Early Wound Healing Index (EHI), it will be evaluated across weeks 2, 4 and 8. (EHI; 1: complete flap closure-no fibrin line; 2: complete flap closure-fine fibrin line; 3: complete flap closure-fibrin clot; 4: incomplete flap closure-partial necrosis; 5: incomplete flap closure-complete necrosis).

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026